The Kidney Cancer Association (KCA) would like to learn more about your experience after undergoing surgery for kidney cancer/renal cell carcinoma (RCC) in order to uncover unmet needs in education, resources and treatment.
In an effort to better assess the current knowledge level surrounding what adjuvant therapy is and how it could play a role for RCC patients who are at high risk of recurrence, we have partnered with CancerCare, Pfizer, Inc. and Kelton, a leading international research firm, to conduct this survey among people who were diagnosed with kidney cancer/RCC and had recent surgery to treat their cancer within the past 6 months to 2 years. The survey takes about 10 to 12 minutes to complete. To access the survey please click on the following link or type the URL in the address bar of your web browser and press “enter:” http://v2.decipherinc.com/survey/selfserve/bb6/180200
If you have any questions, concerns, or problems with the survey, please click here.
KCA, Pfizer, Inc. and Kelton greatly appreciate your help and opinions as your insight will guide the development of educational tools and resources for the RCC community. We value your privacy and pledge never to share your information.
Thank you in advance for your time and participation.